体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体
体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体(In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody)。体内实验级重组嵌合人IgG1 kappa同型对照抗体和突变体(In vivo grade recombinant chimeric human IgG1 kappa isotype control Antibody and mutants)。与经测试的人体样本的特异性结合程度低或无特异性结合。可变区域没有人性化。还提供人性化版本。批量订购价格更低。
- 产品参数
- 文献
- More Offers
货号 | PA007190 |
---|---|
产品名称 | 体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体 |
英文名 | In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody |
供货商名称 | Syd Labs, Inc. |
品牌名 | 悉得(Syd Labs) |
别称 | 嵌合hIgG1同型对照抗体 |
概述 | 体内实验级重组嵌合人IgG1 kappa同型对照抗体和突变体(In vivo grade recombinant chimeric human IgG1 kappa isotype control Antibody and mutants)。与经测试的人体样本的特异性结合程度低或无特异性结合。可变区域没有人性化。还提供人性化版本。批量订购价格更低。 |
克隆号 | 4F17m |
同种型 | 人 IgG1, kappa |
应用 | 用于ELISA、蛋白质印迹 (WB)、流式细胞术(Flow)、免疫沉淀(IP)、免疫组织化学(石蜡)(IHC (P))、免疫组织化学(Frozen) (IHC (F))和体内动物模型研究的人IgG1 kappa抗体的同型匹配阴性对照。 |
免疫源 | N/A |
抗体形式 | 0.2 μM过滤溶液,1x PBS |
内毒素 | 根据 LAL 方法,≤ 1 EU每 1 mg 蛋白质。提供特级体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体(In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody,内毒素≤0.05 EU/mg)。 |
纯度 | >95%(在还原条件下通过SDS-PAGE测定) |
运输 | 体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体(In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody)用冰袋运输。收到后,请立即将其存放在下面建议的温度下。 |
稳定性与存储 | 使用手动除霜冰箱并避免重复冻融循环。 如果保存在2 至 8°C,自收到之日起可保存3个月。如果保存在-20 至 -70°C,自收到之日起可保存 12个月。 |
注意事项 | 体内实验级重组嵌合人IgG1 kappa同型对照抗体和突变体(In vivo grade recombinant chimeric human IgG1 kappa isotype control Antibody and mutants)。与经测试的人体样本的特异性结合程度低或无特异性结合。可变区域没有人性化。还提供人性化版本。批量订购价格更低。 |
线下下单 | 武汉多找找科技有限公司 电话: 18162581039 微信: duozhaozhao2024 Email: message@sydlabs.com |
描述
PA007190: 体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体(In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody)
背景知识
Different from those of the recombinant human IgG1 isotype control antibody and mutants(重组人IgG1同型对照抗体及突变体), the variable regions of the recombinant chimeric human IgG1 isotype control (chimeric hIgG1 kappa isotype control antibody) and mutants(重组嵌合人IgG1同型对照(嵌合hIgG1 kappa同型对照抗体)和突变体) are not humanized. The recombinant chimeric human IgG1 isotype control(重组嵌合人IgG1同型对照) has low or no specific binding to any human sample, and murinized or completely murine variable regions in addition to the human IgG1 kappa constant regions. The chimeric human IgG1 kappa isotype control and mutants(嵌合人IgG1 kappa同型对照和突变体) such as Fc-silenced can be used in ELISA, Western blot (WB), the cell-based assay or animal model as the antibody negative control.
A number of chimeric hIgG1 isotype control mutants(嵌合hIgG1同型对照突变体) are available. Most of the therapeutic antibody drugs carry the natural human IgG1 constant regions. There are some engineered mutants in the IgG1 Fc fragment. Changes to the IgG Fc sequence including glycosylation sites (such as N297A or N297G) have been used to modulate Fc functions. Even a single mutation may have both enhancement and abrogation effects on Fc binding though multiple mutation combinations are commonly used. We generated chimeric hIgG1 isotype control mutants(嵌合hIgG1同型对照突变体), the same mutations as those in the therapeutic antibodies and candidates because such human IgG1 isotype control mutants(人IgG1同型对照突变体) are needed when clients test their engineered antibody candidates. For example, P329G substitution combined with L234A L235A (hIgG1 LALAPG, Fc silenced) was shown to decrease effector functions by disrupting the Fc/Fcγ receptor interface. The silent Fc effctor functions human IgG1 isotype controls(人IgG1同型对照) are useful for in vivo use.
The isotype controls are normally used to differentiate any non-specific background signal from the specific antibody signal, including the immunogenicity if used in animals. Most in vivo functional grade human IgG antibodies(人IgG抗体) are used in mice for in vivo studies. Besides the antibody Complementarity-Determining Regions (CDRs), two human or humanized variable regions including the one in the human or humanized IgG isotype control(人源化IgG同型对照) do not necessarily induce the same immune response in mice because in some cases, even one amino acid difference can make difference. Mouse variable regions can be used to show the potential immunogenicity induced by the human variable regions in the human or humanized IgG antibodies(人源化IgG抗体) to test. Thus, in some cases, it is better to use the mouse variable region in the human IgG isotype controls(人IgG同型对照). We also produce and sell recombinant human IgG isotype controls(重组人IgG同型对照) from the popuplar mouse hybridoma clones, MOPC21 and C1.18.4, as well as recombinant human IgG1 kappa isotype controls(重组人IgG1 kappa同型对照) against KLH, TNP, DNP, GST, HEL, His-tag, Flag, c-myc, HA, GFP, and unknown specificity.
Please contact us to ask for a quote for the Fc silenced chimeric human IgG1 isotype control mutants(Fc silenced嵌合人IgG1同型对照突变体), chimeric hIgG1 isotype control and silent Fc mutants(嵌合hIgG1同型对照和silent Fc突变体) with Avi-, His-, and Flag-tags, and biotinylated chimeric hIgG1 isotype control and Fc silent mutants(嵌合hIgG1同型对照和Fc silent突变体). A variety of conjugates (such as a fluorophore) with the chimeric human IgG1 isotype control and Fc effector-silent mutants(嵌合人IgG1同型对照和Fc effector-silent突变体) are available.
Isotype control antibodies(同型对照抗体) (negative control antibodies or reference antibodies) are frequently used in various antibody-related in vivo and in vitro experiments such as ELISA, Western blot, immunofluorescence, immunohistochemistry, immunoprecipitation, and flow cytometry. Isotype control antibodies(同型对照抗体) are used as negative controls of primary antibodies to check presence of non-specific binding to Fc receptors on the cell surface, other cellular proteins, carbohydrates, and lipids. Thus, the isotype control antibody(同型对照抗体) normally matches the host species and isotype, including light chains (such as human IgG1 kappa antibody(人IgG1 kappa抗体)), concentration, and conjugation format of the experimental primary antibody.
以下突变已被引入以改变IgG1抗体的恒定区,从而通过Fc与宿主蛋白的相互作用改变其免疫特性:
hIgG1 heavy chain R214K
hIgG1 heavy chain R214K/N297A
hIgG1 heavy chain L234A/L235A
hIgG1 heavy chain L234F/L235E/P331S
hIgG1 heavy chain L235A/G237A
hIgG1 heavy chain D356E/L358M
hIgG1 heavy chain F126L
hIgG1 heavy chain D265A
hIgG1 heavy chain F243L/R292P/Y300L/V305I/P396L
hIgG1 heavy chain S239D/I332E
hIgG1 heavy chain S239D/I332E/A330L
hIgG1 heavy chain S298A/E333A/K334A
hIgG1 heavy chain G236A/S239D/I332E
hIgG1 heavy chain K326W/E333S
hIgG1 heavy chain S267E/H268F/S324T
hIgG1 heavy chain E345R/E430G/S440Y
hIgG1 heavy chain N297A
hIgG1 heavy chain N297Q
hIgG1 heavy chain N297G
hIgG1 heavy chain L235E
hIgG1 heavy chain L234A/L235A
hIgG1 heavy chain M252Y/S254T/T256E
hIgG1 heavy chain M428L/N434S
hIgG1 heavy chain S267E/L328F
hIgG1 heavy chain N325S/L328F
其它体内实验级重组IgG同型对照抗体和突变体(in vivo grade Recombinant IgG Isotype Control Antibodies and Mutants):
体内实验级重组人IgG1同型对照抗体和突变体(In vivo Grade Recombinant Human IgG1 Isotype Control Antibody and Mutants)
体内实验级重组人IgG2同型对照抗体(In vivo Grade Recombinant Human IgG2 Isotype Control Antibody)
体内实验级重组人IgG3同型对照抗体(In vivo Grade Recombinant Human IgG3 Isotype Control Antibody)
体内实验级重组人IgG4-S228P同型对照抗体和突变体(In vivo Grade Recombinant Human IgG4-S228P Isotype Control Antibody and Mutants)
体内实验级重组小鼠IgG1同型对照抗体和突变体(In vivo Grade Recombinant Mouse IgG1 Isotype Control Antibody and Mutants)
体内实验级重组小鼠IgG2a同型对照抗体和突变体(In vivo Grade Recombinant Mouse IgG2a Isotype Control Antibody and Mutants)
体内实验级重组小鼠IgG2b同型对照抗体和突变体(In vivo Grade Recombinant Mouse IgG2b Isotype Control Antibody and Mutants)
体内实验级重组小鼠IgG2c同型对照抗体和突变体(In vivo Grade Recombinant Mouse IgG2c Isotype Control Antibody and Mutants)
体内实验级重组小鼠IgG3同型对照抗体(In vivo Grade Recombinant Mouse IgG3 Isotype Control Antibody)
体内实验级重组大鼠IgG1同型对照抗体(In vivo Grade Recombinant Rat IgG1 Isotype Control Antibody)
体内实验级重组大鼠IgG2a同型对照抗体(In vivo Grade Recombinant Rat IgG2a Isotype Control Antibody)
体内实验级重组大鼠IgG2b同型对照抗体(In vivo Grade Recombinant Rat IgG2b Isotype Control Antibody)
体内实验级重组大鼠IgG2c同型对照抗体(In vivo Grade Recombinant Rat IgG2c Isotype Control Antibody)
体内实验级重组仓鼠IgG1同型对照抗体(In vivo Grade Recombinant Hamster IgG1 Isotype Control Antibody)
体内实验级重组仓鼠IgG2同型对照抗体(In vivo Grade Recombinant Hamster IgG2 Isotype Control Antibody)
体内实验级重组IgG Fc蛋白(In vivo Grade Recombinant IgG Fc Proteins):
体内实验级重组人IgG1-Fc蛋白(hIgG1)(In vivo Grade Recombinant Human IgG1 Fc Protein (hIgG1))
体内实验级重组人IgG2-Fc蛋白(hIgG2)(In vivo Grade Recombinant Human IgG2 Fc Protein (hIgG2))
体内实验级重组人IgG4 Fc蛋白(hIgG4)(In vivo Grade Recombinant Human IgG4 Fc Protein (hIgG4))
体内实验级重组小鼠IgG1-Fc蛋白(mIgG1)(In vivo Grade Recombinant Mouse IgG1 Fc Protein (mIgG1))
体内实验级重组小鼠IgG2a-Fc蛋白(mIgG2a)(In vivo Grade Recombinant Mouse IgG2a Fc Protein (mIgG2a))
体内实验级重组小鼠IgG2b-Fc蛋白(mIgG2b)(In vivo Grade Recombinant Mouse IgG2b Fc Protein (mIgG2b))
体内实验级重组大鼠IgG2a-Fc蛋白(rtIgG2a)(In vivo Grade Recombinant Rat IgG2a Fc Protein (rtIgG2a))
体内实验级重组大鼠IgG2b-Fc蛋白(rtIgG2b)(In vivo Grade Recombinant Rat IgG2b Fc Protein (rtIgG2b))
体内实验级重组Llama IgG2b-Fc蛋白(lIgG2b)(In vivo Grade Recombinant Llama IgG2b Fc Protein (lIgG2b))
体内实验级重组兔IgG Fc蛋白(rIgG)(In vivo Grade Recombinant Rabbit IgG Fc Protein (rIgG))
Fc-ELISA试剂盒和试剂(Fc ELISA Kits and Reagents):
人Fc-ELISA试剂盒(Human Fc ELISA Kit)
小鼠Fc-ELISA试剂盒(Mouse Fc ELISA Kit)
人Fc-ELISA试剂盒(Human Fc ELISA Reagent Kit)
小鼠Fc-ELISA试剂盒(Mouse Fc ELISA Reagent Kit)
蛋白质A、树脂、柱和ELISA试剂盒(Protein A, Resin, Columns, and ELISA Kits):
重组蛋白A(Recombinant Protein A)
蛋白A亲和树脂(Protein A Affinity Resin)
预填充蛋白A柱(Pre-packed Protein A Column)
蛋白A ELISA试剂盒(Protein A ELISA Kit)
请记住我们的产品信息: 体内实验级重组嵌合人IgG1-L234A L235A P329G (LALAPG)同型对照抗体: PA007190 Syd Labs (In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (LALAPG) Isotype Control Antibody)